红细胞增多症-话题@MedSci

#红细胞增多症#

26篇内容 | 1577人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1555456, encodeId=5774155545605, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=病例分享：红细胞增多症（原发、继发）2例对比分析, objectType=article, longId=117557, objectId=c57411e557e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c57411e557e7, replyNumber=0, likeNumber=0, createdTime=2017-10-27, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c57411e557e7, moduleTitle=病例分享：红细胞增多症（原发、继发）2例对比分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c57411e557e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555455, encodeId=ec4c155545567, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=Hepatology：王红阳院士发现肝癌患者中红细胞增多症的分子机制, objectType=article, longId=83548, objectId=236a835483a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=236a835483a, replyNumber=0, likeNumber=64, createdTime=2016-12-06, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=236a835483a, moduleTitle=Hepatology：王红阳院士发现肝癌患者中红细胞增多症的分子机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=236a835483a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555454, encodeId=f21815554542a, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=诺华抗癌药Jakavi达真性红细胞增多症III期临床主要终点, objectType=article, longId=71290, objectId=e56ee129027, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e56ee129027, replyNumber=0, likeNumber=61, createdTime=2016-06-22, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e56ee129027, moduleTitle=诺华抗癌药Jakavi达真性红细胞增多症III期临床主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e56ee129027)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555453, encodeId=fe761555453d8, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=诺华重磅药物Jakavi欧盟收获新适应症：真性红细胞增多症（PV）, objectType=article, longId=48434, objectId=d5af48434cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5af48434cb, replyNumber=0, likeNumber=69, createdTime=2015-03-22, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5af48434cb, moduleTitle=诺华重磅药物Jakavi欧盟收获新适应症：真性红细胞增多症（PV）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5af48434cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555452, encodeId=08b0155545253, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=NEJM：Ruxolitinib用于真性红细胞增多症的治疗, objectType=article, longId=47323, objectId=b8f04e3231c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8f04e3231c, replyNumber=0, likeNumber=68, createdTime=2015-02-22, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8f04e3231c, moduleTitle=NEJM：Ruxolitinib用于真性红细胞增多症的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8f04e3231c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555451, encodeId=95991555451e9, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=NEJM：真性红细胞增多症的高强度治疗可减少心血管死亡, objectType=article, longId=15328, objectId=02d41532824, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02d41532824, replyNumber=0, likeNumber=63, createdTime=2013-02-20, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02d41532824, moduleTitle=NEJM：真性红细胞增多症的高强度治疗可减少心血管死亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02d41532824)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

红细胞增多症

2020-05-29

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

病例分享：红细胞增多症（原发、继发）2例对比分析

2017-10-27

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

Hepatology：王红阳院士发现肝癌患者中红细胞增多症的分子机制

2016-12-06

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

诺华抗癌药Jakavi达真性红细胞增多症III期临床主要终点

2016-06-22

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

诺华重磅药物Jakavi欧盟收获新适应症：真性红细胞增多症（PV）

2015-03-22

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

NEJM：Ruxolitinib用于真性红细胞增多症的治疗

2015-02-22

医者仁心 (审核中...)

前往app查看评论内容

#红细胞增多症#

NEJM：真性红细胞增多症的高强度治疗可减少心血管死亡

2013-02-20

科室
- - 订阅+
  - 更多科室
工具
服务